Impact of Lipid Lowering Therapies on the Primary Prevention of Atherosclerotic Cardiovascular Disease

Current Cardiovascular Risk Reports · Published 2025-04-07 · DOI 10.1007/s12170-025-00764-x

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s12170-025-00764-x

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Integrating Digital Coaching into Cardiac Practice: Strategies to Advance Health Equity · Current Cardiovascular Risk Reports · 2024 · Same journal
• Mitral Valve Dysplasia: An Updated Review · Current Cardiovascular Risk Reports · 2024 · Same journal
• Remote Monitoring in Cardiovascular Diseases · Current Cardiovascular Risk Reports · 2023 · Same journal
• Compounded GLP-1 Receptor Agonists in the Post-Shortage Era: Costs, Safety and Regulatory Challenges · Current Cardiovascular Risk Reports · 2026 · Same journal
• Addressing Disparities in the Screening and Treatment of Dyslipidemia – A Call to Action · Current Cardiovascular Risk Reports · 2025 · Same journal
• Artificial Intelligence Across the Continuum of Atrial Fibrillation Screening, Diagnosis, and Treatment · Current Cardiovascular Risk Reports · 2024 · Same journal
• Racial and Ethnic Disparities in Heart Failure with Preserved Ejection Fraction: Epidemiology, Diagnosis, Management and Outcomes · Current Cardiovascular Risk Reports · 2024 · Same journal
• Contemporary Approaches And Treatment Strategies To Avoid Esophageal Injury During Atrial Fibrillation Ablation · Current Cardiovascular Risk Reports · 2024 · Same journal
• Leveraging Digital Health to Improve the Cardiovascular Health of Women · Current Cardiovascular Risk Reports · 2023 · Same journal
• Hypertension Management to Reduce Racial/Ethnic Disparities: Clinical and Community-Based Interventions · Current Cardiovascular Risk Reports · 2024 · Same journal